Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective study of roxadustat to reduce delayed graft function and acute rejection after kidney transplantation
ChiCTR2000032858Phase 4Recruiting
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of roxadustat in delayed graft function (DGF) and kidney allograft rejection (2 arms), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Incidence of delayed graft function and Incidence of acute rejection. Started Jul 2020; status: recruiting.
02
Drugs
roxadustat
03
Conditions
delayed graft function (DGF)kidney allograft rejection
Beyond the preview
Go deeper on ChiCTR2000032858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032858.